Since MAPT mutations were first identified in 1998, 8 years before PGRN was discovered, and 13 years before C9orf72 was discovered, the large number of papers dealing with MAPT mutations may have artificially skewed the prevalence findings to appear that MAPT has a significantly higher proportion of movement disorders in its clinical presentation. This evidence concerns the gene C9orf72 and movement disorder.